does blue cross cover tirzepatide for weight loss blue shield glp-1 Why we are changing coverage of GLP-1 drugs Does Blue Cross Blue Shield

N Engl J Med 385(17):15471558 Nakajima A, Eguchi Y, Yoneda M, Imajo K, Tamaki N, Suganami H et al (2021) Randomised clinical trial: pemafibrate, a novel selective peroxisome proliferator-activated receptor modulator (SPPARM), versus placebo in patients with non-alcoholic fatty liver disease

The relationship is dose-dependent but plateaus over time

Leveraging time with lifestyle-based group visits

As with any medication, its essential to consult with a healthcare provider to determine if GLP-1 therapy is appropriate for your individual needs and to create a comprehensive plan for achieving and maintaining a healthy weight

For the time being, tirzepatide remains the superior option for many people thinking about GLP-1 therapy for their obesity or type 2 diabetes, though it does tend to cost more than semaglutide